These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 757385)

  • 1. Immunocompetent cells in malignant disease in man. II. Clinical and immunologic correlates in a case of non-Hodgkin's lymphoma.
    Algom D; Rapp E; Hamdy H; Keaney MA; Hirte W; Klaassen DJ; Richter M
    Can Med Assoc J; 1978 Jan; 118(2):168-71. PubMed ID: 757385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immunity in long-term surviving patients with malignant lymphoma.
    Opat P; Kolár V; Lauerová L; Pintera J; Zemanová D
    Neoplasma; 1980; 27(3):301-6. PubMed ID: 7453850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of immunocompetence in Hodgkin's disease.
    Faguet GB
    J Clin Invest; 1975 Oct; 56(4):951-7. PubMed ID: 1159096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune deficiency in Hodgkin and non-Hodgkin lymphoma.
    El-Haddad SI; El-Ashmawy S; Hassan W; George E; Ali FM; Sharaf MA; Mahfouz M
    Biomedicine; 1980 Oct; 32(3):128-33. PubMed ID: 7448322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical diagnosis and surgical treatment of primary pulmonary lymphoma].
    Zhang LB; Sun YE; Yu CH; Liu Y
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):97-9. PubMed ID: 16620666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocompetence and malignant lymphoma: immunologic status before therapy.
    Anderson TC; Jones SE; Soehnlen BJ; Moon TE; Griffith K; Stanley P
    Cancer; 1981 Dec; 48(12):2702-9. PubMed ID: 6458352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophoretic mobility of peripheral non-B human Fc gamma-receptors bearing lymphocytes.
    Chollet P; Chassagne J; Thierry C; Gauvin H; Vuillaume C; Serrou B; Plagne R
    Biomedicine; 1980 Feb; 32(1):31-41. PubMed ID: 6966164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Objective regressions of T- and B-cell lymphomas in patients following treatment with anti-thymocyte globulin.
    Fisher RI; Silver BA; Vanhaelen CP; Jaffe ES; Cossman J
    Cancer Res; 1982 Jun; 42(6):2465-9. PubMed ID: 7042086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosette formation in non Hodgkin's lymphoma in the bone marrow--a case report.
    Kurien A; Manohar C; Mathew M; Rao L
    Indian J Pathol Microbiol; 2004 Jan; 47(1):34-5. PubMed ID: 15471122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
    Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
    Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface receptors and immune activity of purified human mononuclear cells. II. The lack of correlation between rosette formation and ADCC cytotoxic activity.
    Richter M; Sklar S
    Clin Invest Med; 1983; 6(3):185-90. PubMed ID: 6652984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological profile in patients with non-Hodgkin's lymphomas.
    Urasiński I; Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):467-74. PubMed ID: 6689470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of an antitumor multipeptide complex on immunocompetent and antigen-responsive cells.
    De Barbieri A; Golferini A; Brugo A; Omesso A; Tassi GC
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):201-15. PubMed ID: 1087883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear morphology and morphometry of B-lymphocyte transformation. Implications for follicular center cell lymphomas.
    Dardick I; Sinnott NM; Hall R; Bajenko-Carr TA; Setterfield G
    Am J Pathol; 1983 Apr; 111(1):35-49. PubMed ID: 6340518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of IgG lambda lymphoma occurring in a patient with previous IgG kappa lymphoma.
    Lowenthal RM; Harlow RW
    Aust N Z J Med; 1981 Jun; 11(3):281-4. PubMed ID: 6794557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.